You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 11, 2024

Lorazepam - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for lorazepam and what is the scope of freedom to operate?

Lorazepam is the generic ingredient in six branded drugs marketed by Almatica, Amneal Pharms, Chartwell Molecular, Hikma, Lupin Ltd, Pharm Assoc, Bedford, Dava Pharms Inc, Dr Reddys, Epic Pharma Llc, Hospira, Intl Medication Sys, Rising, Watson Labs, Bedford Labs, Roxane, Bausch, Quantum Pharmics, Am Therap, Anda Repository, Ani Pharms, Aurolife Pharma Llc, Chartwell Rx, Halsey, Leading, Mutual Pharm, Oxford Pharms, Par Pharm, Sandoz, Sun Pharm Inds Ltd, Superpharm, Usl Pharma, and Warner Chilcott, and is included in seventy NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Lorazepam has thirty-five patent family members in thirty countries.

There are eleven drug master file entries for lorazepam. Thirty-seven suppliers are listed for this compound.

Summary for lorazepam

International Patents:	35
US Patents:	1
Tradenames:	6
Applicants:	33
NDAs:	70
Drug Master File Entries:	11
Finished Product Suppliers / Packagers:	37
Raw Ingredient (Bulk) Api Vendors:	50
Clinical Trials:	195
Patent Applications:	6,998
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for lorazepam
Drug Sales Revenues:	Drug sales revenues for lorazepam
What excipients (inactive ingredients) are in lorazepam?	lorazepam excipients list
DailyMed Link:	lorazepam at DailyMed

See drug prices for lorazepam

See drug sales revenues for lorazepam

Recent Clinical Trials for lorazepam

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Colorado, Denver	Phase 2
Children's Hospital Los Angeles	Phase 2
University of Calgary	Phase 2

See all lorazepam clinical trials

Pharmacology for lorazepam

Drug Class	Benzodiazepine

Medical Subject Heading (MeSH) Categories for lorazepam

Anti-Anxiety Agents
Anticonvulsants
Antiemetics
GABA Modulators
Hypnotics and Sedatives

Anatomical Therapeutic Chemical (ATC) Classes for lorazepam

N05BA	Benzodiazepine derivatives
N05B	ANXIOLYTICS
N05	PSYCHOLEPTICS
N	Nervous system

US Patents and Regulatory Information for lorazepam

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Oxford Pharms	LORAZEPAM	lorazepam	TABLET;ORAL	077754-002	May 10, 2006	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Rising	LORAZEPAM	lorazepam	INJECTABLE;INJECTION	200542-002	Apr 28, 2017		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Pharm Assoc	LORAZEPAM	lorazepam	CONCENTRATE;ORAL	090260-001	Jun 15, 2010	AA	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Amneal Pharms	LORAZEPAM	lorazepam	CONCENTRATE;ORAL	091383-001	Dec 23, 2009	AA	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Amneal Pharms	LORAZEPAM	lorazepam	TABLET;ORAL	078826-001	Jun 23, 2010		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Hikma	ATIVAN	lorazepam	INJECTABLE;INJECTION	018140-001	Approved Prior to Jan 1, 1982	AP	RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for lorazepam

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Hikma	ATIVAN	lorazepam	INJECTABLE;INJECTION	018140-001	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Hikma	ATIVAN	lorazepam	INJECTABLE;INJECTION	018140-002	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for lorazepam

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Slovenia	2943185		⤷ Try a Trial
China	105209018	Sustained release formulations of lorazepam	⤷ Try a Trial
Cyprus	1123933		⤷ Try a Trial
Peru	20151432	FORMULACIONES DE LORAZEPAM DE LIBERACION SOSTENIDA	⤷ Try a Trial
Spain	2856181		⤷ Try a Trial
Mexico	367364	FORMULACIONES DE LORAZEPAM DE LIBERACIÓN SOSTENIDA. (SUSTAINED RELEASE FORMULATIONS OF LORAZEPAM.)	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.